Financing prevention, rewriting drug pricing: the Change Initiative’s new website goes live

Abstract geometric illustration in purple, blue, pink, and yellow gradients, representing the Change Initiative's collaborative, multi-perspective approach to global health.

The Office of Health Economics (OHE) has unveiled a new website for the Change Initiative, a pioneering initiative convened by the OHE, leveraging the collective expertise and insights of an expanding community of the world’s leading organisations in health and care.

This new website showcases the two flagship research programmes launched by the Change Initiative: how to finance prevention, and how US pharmaceutical pricing reform is reshaping access to medicines worldwide.

Addressing systemic challenges in financing prevention

Despite overwhelming evidence into the cost-effectiveness of prevention, healthcare spending around the world remains heavily weighted toward acute and reactive care, while the interventions most likely to keep people healthy, and reduce long-term costs, remain chronically underfunded.


The Financing Prevention programme sets out to understand the structural reasons for why prevention is underfunded, and investigates what a sustainable prevention financing architecture might look like. 

Working with partners across sectors, the initiative examines alternative financing and contracting models, from outcomes-based payment to cross-sector investment vehicles and develops practical, actionable recommendations for governments, health systems, and private partners.

Find out more: Financing Prevention: Unlocking Investment in a Healthier Future – Change Initiative

From Washington to the world: US Policy Horizon series

Landmark reforms in the United States, including the Inflation Reduction Act and the Trump administration’s Most Favored Nation pricing policy,  are rapidly reshaping the economics of drug development, pricing, and access both in the US and around the world.

The US Policy Horizon Series examines these shifts from a global perspective. Through a multi-part programme of independent research and policy engagement, the Series unpacks the implications for launch sequencing, value assessment, and market access across Europe, Asia, and beyond and explores what a globally equitable approach to pharmaceutical pricing might look like. 

Find out more: US Policy Horizon Series: From Washington to the World – Change Initiative

For more information on the Change Initiative, visit the new website at Home – Change Initiative